New arrivals

Made with care and unconditionally loved by our customers.

Shop Now

Product Details for Medical and PHA Raw Materials Wholesale

Product Advantages

Good biocompatibility, controllable degradation, high bioactivity, low inflammation, no disintegration, non-immunogenic, adjustable mechanical properties

technological advantages

Refined high-purity green extraction, breakthrough in process scale-up, full coverage of upstream and downstream technologies

Industry status

The world's first PHA medical materials supplier, with Gaia Recycling's capacity achieving a production value of over 100 million

Covering both consumer healthcare and professional (or serious) healthcare

Consumer healthcare

【Aesthetic microspheres and monofilaments】Microsphere carrier——Medical-aesthetic microspheres, drug carriers, and cell-implantable microspheres.
Tissue filling material——
Bone filling, dental materials, and intraocular filling materials

“By 2032, the global aesthetic medicine market is expected to reach 4.32 billion USD, with a continued increase in demand for microsphere-based products.”





Shop now

Professional healthcare

【Sustained drug release and tissue repair scaffolds】Scaffold materials——Cardiac stents, vascular stents, and esophageal stents



Shop now

Medical PHA Focused Market

For mobile devices, please manually slide the progress bar below. Thank you!

Clinical/Production Progress of Products Under Development

Registration Progress(P34HB)
Pipeline
Project Early Research
Product Validation
Product Finalization
Animal Testing
Registration Inspection
Clinical Trials
Registration Approval
Raw Material
Microsphere
Monofilament
Membrane
Mass Production Progress(P34HB)
Pipeline
Laboratory R&D
Small-Scale Validation
Pilot-Scale Validation
Scale-Up Production
Raw Material
Microsphere
Monofilament
Membrane
Types of Partner Customers Consumer Healthcare - Leading Medical Aesthetics Company HConsumer Healthcare - Startup Medical Aesthetics Company Serious Healthcare - Emerging Company Serious Healthcare - Leading Listed Medical Device Company
Product Type P34HB microspheres, filler type P34HB microspheres, filler type Medical monofilament Stent/Coating
Form of Cooperation Raw Materials + Joint Development + Government Collaboration Project Raw material + microsphere process output Raw material supply + technical process output Raw material supply
Collaboration Progress The pilot production line has been established and is about to undergo pilot testing/registration inspection. Completed registration inspection in 2024 Small-batch trial use Small-batch trial use
Future Expectations Obtained clinical approval in 2025 Obtained clinical approval in 2025 Registration inspection in 2025 Innovative medical device

Gaiacycle Materials

PHA Raw Materials Supplier

If you are interested or have any questions, please send an email or add us on WhatsApp to contact us.